PL3490526T3 - Wodny roztwór izotonicznego krystaloidu - Google Patents
Wodny roztwór izotonicznego krystaloiduInfo
- Publication number
- PL3490526T3 PL3490526T3 PL17740398T PL17740398T PL3490526T3 PL 3490526 T3 PL3490526 T3 PL 3490526T3 PL 17740398 T PL17740398 T PL 17740398T PL 17740398 T PL17740398 T PL 17740398T PL 3490526 T3 PL3490526 T3 PL 3490526T3
- Authority
- PL
- Poland
- Prior art keywords
- aqueous solution
- isotonic crystalloid
- crystalloid aqueous
- isotonic
- solution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/241—Lead; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/242—Gold; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201631021A ES2651717B1 (es) | 2016-07-26 | 2016-07-26 | Solución acuosa cristaloide isotónica |
| EP17740398.7A EP3490526B1 (en) | 2016-07-26 | 2017-07-18 | Isotonic crystalloid aqueous solution |
| PCT/EP2017/068141 WO2018019663A1 (en) | 2016-07-26 | 2017-07-18 | Isotonic crystalloid aqueous solution |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3490526T3 true PL3490526T3 (pl) | 2021-03-08 |
Family
ID=59363165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17740398T PL3490526T3 (pl) | 2016-07-26 | 2017-07-18 | Wodny roztwór izotonicznego krystaloidu |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US11426427B2 (pl) |
| EP (1) | EP3490526B1 (pl) |
| JP (1) | JP6976326B2 (pl) |
| KR (1) | KR102404536B1 (pl) |
| CN (1) | CN109789087B (pl) |
| AU (1) | AU2017304376A1 (pl) |
| BR (1) | BR112019001621A2 (pl) |
| CA (1) | CA3031845A1 (pl) |
| DK (1) | DK3490526T3 (pl) |
| ES (2) | ES2651717B1 (pl) |
| HU (1) | HUE051026T2 (pl) |
| MX (1) | MX2019001077A (pl) |
| PL (1) | PL3490526T3 (pl) |
| PT (1) | PT3490526T (pl) |
| RU (1) | RU2739561C2 (pl) |
| WO (1) | WO2018019663A1 (pl) |
| ZA (1) | ZA201900542B (pl) |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9406742A (pt) * | 1993-06-04 | 1996-03-12 | Biotime Inc | Solução semelhante ao plasma |
| US6680305B1 (en) * | 1993-06-04 | 2004-01-20 | Biotime, Inc. | Physiologically acceptable aqueous solutions and methods for their use |
| US6940827B2 (en) * | 2001-03-09 | 2005-09-06 | Adaptix, Inc. | Communication system using OFDM for one direction and DSSS for another direction |
| US20030153491A1 (en) * | 2002-01-11 | 2003-08-14 | Winslow Robert M. | Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
| KR100478982B1 (ko) | 2002-05-02 | 2005-03-25 | 금호석유화학 주식회사 | 신규 산발생제 및 이를 함유한 박막 조성물 |
| US7498039B2 (en) * | 2002-10-10 | 2009-03-03 | Thompson Diana F | Nutritional supplement containing sea water minerals |
| AU2004255268B2 (en) * | 2003-07-09 | 2010-04-01 | Loma Linda University | Use of nitrite salts for the treatment of cardiovascular conditions |
| US7362274B1 (en) * | 2004-07-09 | 2008-04-22 | Huan-Cheng Lien | Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna |
| US7759306B2 (en) * | 2006-05-16 | 2010-07-20 | Simoni Jan S | Methods of treating acute blood loss |
| CN101790306A (zh) | 2007-02-17 | 2010-07-28 | 哈佛学院董事会 | 用于进行组织保存的组合物以及方法 |
| US20090209550A1 (en) | 2008-02-20 | 2009-08-20 | Auspex Pharmaceuticals, Inc. | Substituted triazolopyridines |
| ES2343777B1 (es) | 2009-01-14 | 2011-05-25 | Laboratoires Quinton International S.L | Procedimiento de recogida y envasado farmaceutico de agua de mar. |
| DE102009034132A1 (de) * | 2009-07-20 | 2011-01-27 | B. Braun Melsungen Ag | Plasmaadaptierte und balancierte Gelatinelösung |
| RU2423987C1 (ru) * | 2009-12-31 | 2011-07-20 | Государственное образовательное учреждение высшего профессионального образования САНКТ-ПЕТЕРБУРГСКАЯ ГОСУДАРСТВЕННАЯ ХИМИКО-ФАРМАЦЕВТИЧЕСКАЯ АКАДЕМИЯ Федерального агентства по здравоохранению и социальному развитию (ГОУ ВПО СПХФА Росздрава) | Инфузионный раствор для восполнения объема циркулирующей крови, восстановления водно-электролитного баланса и нормализации процессов кроветворения |
| EP2717879B1 (en) * | 2011-06-10 | 2017-08-16 | Queen Mary University of London | Artemisinin and derivatives for use in the treatment of trauma haemorrhage |
| EP2817014A2 (en) * | 2012-02-21 | 2014-12-31 | Baxter International Inc | Pharmaceutical composition comprising cd34+ cells |
| CN103989704A (zh) * | 2013-02-19 | 2014-08-20 | B.布劳恩梅尔松根股份公司 | 用于输液的电解质水溶液 |
| AU2014264537B2 (en) * | 2013-05-08 | 2018-10-18 | Gambro Lundia Ab | Dialysis formulation |
-
2016
- 2016-07-26 ES ES201631021A patent/ES2651717B1/es not_active Expired - Fee Related
-
2017
- 2017-07-18 HU HUE17740398A patent/HUE051026T2/hu unknown
- 2017-07-18 AU AU2017304376A patent/AU2017304376A1/en not_active Abandoned
- 2017-07-18 PT PT177403987T patent/PT3490526T/pt unknown
- 2017-07-18 DK DK17740398.7T patent/DK3490526T3/da active
- 2017-07-18 CA CA3031845A patent/CA3031845A1/en active Pending
- 2017-07-18 JP JP2019526363A patent/JP6976326B2/ja active Active
- 2017-07-18 EP EP17740398.7A patent/EP3490526B1/en active Active
- 2017-07-18 US US16/320,706 patent/US11426427B2/en active Active
- 2017-07-18 BR BR112019001621-0A patent/BR112019001621A2/pt active Search and Examination
- 2017-07-18 ES ES17740398T patent/ES2811354T3/es active Active
- 2017-07-18 CN CN201780058883.3A patent/CN109789087B/zh active Active
- 2017-07-18 KR KR1020197005326A patent/KR102404536B1/ko active IP Right Grant
- 2017-07-18 WO PCT/EP2017/068141 patent/WO2018019663A1/en unknown
- 2017-07-18 RU RU2019102162A patent/RU2739561C2/ru active
- 2017-07-18 PL PL17740398T patent/PL3490526T3/pl unknown
- 2017-07-18 MX MX2019001077A patent/MX2019001077A/es unknown
-
2019
- 2019-01-25 ZA ZA2019/00542A patent/ZA201900542B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20210308179A1 (en) | 2021-10-07 |
| US11426427B2 (en) | 2022-08-30 |
| BR112019001621A2 (pt) | 2019-04-30 |
| JP2019522060A (ja) | 2019-08-08 |
| ES2651717B1 (es) | 2018-11-16 |
| AU2017304376A1 (en) | 2019-02-14 |
| RU2019102162A3 (pl) | 2020-08-26 |
| DK3490526T3 (da) | 2020-08-17 |
| MX2019001077A (es) | 2019-08-29 |
| RU2019102162A (ru) | 2020-08-26 |
| KR102404536B1 (ko) | 2022-05-31 |
| KR20190039156A (ko) | 2019-04-10 |
| CA3031845A1 (en) | 2018-02-01 |
| RU2739561C2 (ru) | 2020-12-25 |
| EP3490526B1 (en) | 2020-05-13 |
| ES2811354T3 (es) | 2021-03-11 |
| WO2018019663A1 (en) | 2018-02-01 |
| ES2651717A1 (es) | 2018-01-29 |
| HUE051026T2 (hu) | 2021-03-01 |
| EP3490526A1 (en) | 2019-06-05 |
| ZA201900542B (en) | 2022-08-31 |
| CN109789087B (zh) | 2022-12-20 |
| PT3490526T (pt) | 2020-08-21 |
| JP6976326B2 (ja) | 2021-12-08 |
| CN109789087A (zh) | 2019-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201419865D0 (en) | Solution | |
| DK3122672T3 (da) | Griber | |
| DK3286040T3 (da) | Containermonteringsanordning | |
| SG10201502448TA (en) | Self-assembling polymers - i | |
| DK3288988T3 (da) | Vandige dispersioner | |
| UA32259S (uk) | Розприскувач | |
| DK3310675T3 (da) | Dåselåg | |
| HK1252945A1 (zh) | 次氯酸水溶液 | |
| SG11201705138QA (en) | Aqueous ophthalmic solution | |
| GB201609143D0 (en) | Winglet | |
| DE112015003457A5 (de) | Al-Gusslegierung | |
| BR112017014838A2 (pt) | benzoxaboróis microbicidas | |
| GB201503603D0 (en) | SERS active nanoparticles | |
| SG11201704740WA (en) | Aqueous composition | |
| DK3377417T3 (da) | Dåselåg | |
| DK3375874T3 (da) | Forbedret paramyxovirus-vektor | |
| ZA201604864B (en) | Aqueous herbicidal concentrates | |
| GB201609142D0 (en) | Winglet | |
| FI20145032A (fi) | Nasta | |
| GB201701939D0 (en) | Salt | |
| EP2952189A4 (en) | CLEAN AQUEOUS SOLUTION | |
| DK3199160T3 (da) | Vandig sammensætning | |
| KR20180084978A (ko) | 피스톤-챔버 조합체 | |
| ZA201900542B (en) | Isotonic crystalloid aqueous solution | |
| GB201610959D0 (en) | Winglet |